X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7517) 7517
Newsletter (760) 760
Publication (512) 512
Book Review (45) 45
Book Chapter (35) 35
Newspaper Article (31) 31
Conference Proceeding (12) 12
Book / eBook (7) 7
Dissertation (6) 6
Magazine Article (5) 5
Transcript (4) 4
Trade Publication Article (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4847) 4847
male (3221) 3221
animals (2815) 2815
kallikrein (2472) 2472
kallikreins - blood (1980) 1980
female (1686) 1686
index medicus (1646) 1646
middle aged (1474) 1474
rats (1361) 1361
adult (1246) 1246
aged (1018) 1018
kallikreins - metabolism (964) 964
research (942) 942
prostate-specific antigen - blood (901) 901
prostate cancer (845) 845
bradykinin (752) 752
kallikreins - urine (720) 720
cancer (651) 651
prostatic neoplasms - blood (588) 588
urology & nephrology (572) 572
kinins - blood (556) 556
blood pressure - drug effects (533) 533
kallikrein-kinin system (514) 514
time factors (482) 482
kallikreins - antagonists & inhibitors (478) 478
pharmacology & pharmacy (465) 465
biochemistry & molecular biology (463) 463
blood pressure (452) 452
mice (441) 441
prostatic neoplasms - pathology (431) 431
prostate-specific antigen (426) 426
peripheral vascular disease (421) 421
oncology (417) 417
hypertension (409) 409
molecular weight (407) 407
analysis (388) 388
kallikreins - physiology (372) 372
kinetics (369) 369
renin - blood (369) 369
kallikreins - pharmacology (364) 364
reports (361) 361
kininogens - blood (358) 358
expression (353) 353
hematology (342) 342
blood coagulation (338) 338
risk factors (334) 334
kallikreins - analysis (331) 331
prostatic neoplasms - diagnosis (321) 321
adolescent (316) 316
kinins - metabolism (312) 312
amino acid sequence (311) 311
inflammation (309) 309
kallikreins (308) 308
molecular sequence data (301) 301
bradykinin - pharmacology (299) 299
aged, 80 and over (298) 298
hypertension - physiopathology (298) 298
tissue kallikrein (292) 292
dogs (289) 289
diagnosis (288) 288
prognosis (286) 286
immunology (282) 282
kallikreins - genetics (278) 278
plasma kallikrein (278) 278
rabbits (277) 277
health aspects (272) 272
activation (269) 269
enzyme activation (262) 262
kinins - physiology (261) 261
fibrinolysis (257) 257
kallikrein-kinin system - physiology (255) 255
medicine, research & experimental (253) 253
physiological aspects (253) 253
plasma (253) 253
kinins (247) 247
treatment outcome (247) 247
research article (245) 245
factor xii - metabolism (243) 243
enzymes (237) 237
in vitro techniques (237) 237
proteins (235) 235
article (234) 234
blood-pressure (232) 232
proteases (229) 229
rats, inbred strains (228) 228
urology (228) 228
prekallikrein - analysis (224) 224
radical prostatectomy (223) 223
physiology (220) 220
men (219) 219
kidney - metabolism (218) 218
care and treatment (215) 215
urinary kallikrein (212) 212
prekallikrein (211) 211
biopsy (209) 209
molecular-weight kininogen (208) 208
oncology, experimental (207) 207
antigens (204) 204
biomarkers, tumor - blood (204) 204
genetic aspects (203) 203
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7237) 7237
Russian (604) 604
Japanese (147) 147
German (144) 144
French (61) 61
Polish (51) 51
Italian (33) 33
Spanish (22) 22
Chinese (12) 12
Ukrainian (10) 10
Czech (6) 6
Bulgarian (5) 5
Romanian (4) 4
Portuguese (3) 3
Dutch (2) 2
Norwegian (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BioMed Research International, ISSN 2314-6133, 2015, Volume 2015, pp. 490531 - 16
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2005, Volume 99, Issue 2, pp. 267 - 277
When ovarian carcinoma is diagnosed in stage I, up to 90% of patients can be cured with surgery and currently available chemotherapy. At present, less than 25%... 
HK6 | Claudin 3 | Tumor markers | HK10 | Ovarian carcinoma | CA125 | Osteopontin | FACTOR VEGF | DIAGNOSIS | tumor markers | osteopontin | ovarian carcinoma | SERUM | HUMAN TISSUE KALLIKREINS | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | claudin 3 | ONCOLOGY | GENE-EXPRESSION | PATIENT SURVIVAL | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Epididymal Secretory Proteins - biosynthesis | Immunohistochemistry | Vascular Endothelial Growth Factor A - biosynthesis | Epithelial Cells - metabolism | Kallikreins - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | Middle Aged | Antigens, Neoplasm - biosynthesis | GPI-Linked Proteins | Ovarian Neoplasms - pathology | beta-Defensins | Sialoglycoproteins - biosynthesis | Antigens - blood | CA-125 Antigen - biosynthesis | CA-19-9 Antigen - biosynthesis | Antigens, Neoplasm - blood | Female | Kallikreins - blood | Ovarian Neoplasms - metabolism | CA-19-9 Antigen - blood | Membrane Proteins - blood | Cystadenoma - metabolism | CA-125 Antigen - blood | Vascular Endothelial Growth Factor A - blood | Membrane Glycoproteins - blood | Ovarian Neoplasms - blood | Sialoglycoproteins - blood | Epithelial Cells - pathology | Glycoproteins - blood | Cystadenoma - blood | Claudin-3 | Mucin-1 | Mucins - blood | Biomarkers, Tumor - blood | Glycoproteins - biosynthesis | Mucins - biosynthesis | Membrane Proteins - biosynthesis | Epididymal Secretory Proteins - metabolism | Antigens - biosynthesis | Neoplasm Staging | Biomarkers, Tumor - biosynthesis | Antigens | Chemotherapy | Oncology, Experimental | Flexible response (Strategy) | Research | Universities and colleges | Deterrence (Strategy) | Cancer | Ovarian cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 726 - 734
Purpose: We evaluated the association of PSA and androgen receptor splice variant-7 (AR-V7) transcript levels in patients' blood with time to treatment failure... 
ANDROGEN-DEPRIVATION THERAPY | DROPLET DIGITAL PCR | POLYMERASE-CHAIN-REACTION | ONCOLOGY | RESISTANCE | RECEPTOR | MECHANISMS | PROGNOSTIC-SIGNIFICANCE | INCREASED SURVIVAL | SPLICE VARIANTS | CHEMOTHERAPY | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prognosis | Phenylthiohydantoin - therapeutic use | Humans | Middle Aged | Male | RNA, Neoplasm - blood | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Kallikreins - blood | Retrospective Studies | Prostatic Neoplasms - drug therapy | Prostate-Specific Antigen - genetics | Adenocarcinoma - blood | Kallikreins - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Abiraterone Acetate - therapeutic use | Adenocarcinoma - drug therapy | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Biomarkers, Tumor - blood | Androgens | Neoplasms, Hormone-Dependent - blood | RNA, Messenger - blood | Receptors, Androgen - genetics | Androgen Antagonists - therapeutic use | Aged | Neoplasms, Hormone-Dependent - drug therapy | Protein Isoforms - genetics | Alternative splicing | Statistical analysis | Transcription | Tumor cells | Prostate-specific antigen | Regression analysis | Gene expression | Ribonucleic acid--RNA | Patients | Blood | Confidence intervals | Castration | Experimental design | Medical prognosis | Peripheral blood | Biomarkers | Bioindicators | Acetic acid | Prostate cancer | Prostate | Cancer
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 11/2011, Volume 58, Issue 5, pp. 514 - 521
ABSTRACTRosmarinic acid (RA), a caffeic acid ester, has insulin-sensitizing and antioxidant effects in high fructose-fed model of insulin resistance (IR). This... 
blood pressure | rosmarinic acid | insulin resistance | heart | nicotinamide adenine dinucleotide phosphate reduced oxidase | CARDIAC & CARDIOVASCULAR SYSTEMS | LIPID-METABOLISM | ATHEROSCLEROSIS | OXIDATION PROTEIN PRODUCTS | INSULIN SENSITIVITY | SUPEROXIDE ANION | REACTIVE OXYGEN | DIET | ADENINE-DINUCLEOTIDE | PHARMACOLOGY & PHARMACY | COMPLICATIONS | STRESS | Gene Expression - drug effects | Rats, Wistar | Antioxidants - metabolism | NADPH Oxidases - metabolism | Body Weight - drug effects | Male | Insulin - blood | Troponin C - blood | Depsides - pharmacology | Hypertension - etiology | Peptidyl-Dipeptidase A - blood | Fructose - pharmacology | Insulin Resistance - physiology | Lipids - blood | Myocardium - metabolism | Depsides - therapeutic use | Hypertension - prevention & control | Blood Pressure - drug effects | Blood Pressure - physiology | Kallikreins - blood | Nitric Oxide Synthase Type III - metabolism | Hyperinsulinism - blood | Nitrates - blood | Hyperinsulinism - prevention & control | Dietary Carbohydrates - pharmacology | Endothelin-1 - metabolism | Rats | Myocardium - pathology | Cinnamates - pharmacology | Hypertension - physiopathology | Blood Glucose - drug effects | Organ Size - drug effects | Animals | Aspartate Aminotransferases - blood | L-Lactate Dehydrogenase - blood | Lipid Metabolism - drug effects | Creatine Kinase, MB Form - blood | Heart - drug effects | Oxidative Stress - drug effects | Cinnamates - therapeutic use | Fructose - administration & dosage
Journal Article
Journal Article
Journal Article
Thrombosis Research, ISSN 0049-3848, 11/2015, Volume 136, Issue 5, pp. 1018 - 1021
Introduction Classical reference data concerning the coagulation system and fibrinolysis in fetuses and newborns date back to the 1990s. Since that time a... 
Contact Activation System factors | Cord blood | KALLIKREIN | NEWBORN | THROMBOSIS | MOLECULAR-WEIGHT KININOGEN | FACTOR-XII | PLASMA | INFANTS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | HEMOSTASIS | PREKALLIKREIN | NEONATE | Young Adult | Pilot Projects | Humans | Adult | Female | Fetal Blood - cytology | Fetal Blood - metabolism | Pregnancy - blood
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 12/2007, Volume 27, Issue 12, pp. 2507 - 2513
Formation of a fibrin clot is mediated by a group of tightly regulated plasma proteases and cofactors. While this system is essential for minimizing blood loss... 
Arterial thrombosis | Coagulation | Intrinsic pathways | VENOUS THROMBOSIS | DEEP-VEIN THROMBOSIS | coagulation | VON-WILLEBRAND-FACTOR | VERTEBRATE BLOOD-COAGULATION | KALLIKREIN-KININ SYSTEM | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | 14 SWISS FAMILIES | intrinsic pathways | arterial thrombosis | FACTOR-XI DEFICIENCY | CORONARY-HEART-DISEASE | HEMATOLOGY | TISSUE FACTOR | Reperfusion Injury - etiology | Factor XII Deficiency - blood | Humans | Reperfusion Injury - blood | Factor XI - antagonists & inhibitors | Protease Inhibitors - pharmacology | Thromboembolism - prevention & control | Infarction, Middle Cerebral Artery - complications | Factor XII Deficiency - genetics | Thrombosis - blood | Thrombosis - prevention & control | Protease Inhibitors - therapeutic use | Thromboembolism - genetics | Disease Models, Animal | Hemostasis - drug effects | Factor XI - genetics | Factor XII - genetics | Anticoagulants - therapeutic use | Hemostasis - genetics | Infarction, Middle Cerebral Artery - blood | Mice, Knockout | Factor XI Deficiency - blood | Animals | Thromboembolism - blood | Blood Coagulation - drug effects | Anticoagulants - pharmacology | Factor XII - antagonists & inhibitors | Factor XII - metabolism | Blood Coagulation - genetics | Thrombosis - genetics | Mice | Factor XI - metabolism | Fibrin - metabolism | Factor XI Deficiency - genetics
Journal Article